Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Candel Therapeutics Inc (CADL)

Candel Therapeutics Inc (CADL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Candel Therapeutics Inc 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 USA

www.candeltx.com Employees: 38 P: 617-916-5445

Sector:

Medical

Description:

Candel Therapeutics Inc. is a late clinical stage biopharmaceutical company. It involved in developing novel oncolytic viral immunotherapies. The company's product pipeline includes CAN-2409 and CAN-3110. Candel Therapeutics Inc. is based in NEEDHAM, Mass.

Key Statistics

Overview:

Market Capitalization, $K 351,347
Enterprise Value, $K 261,197
Shares Outstanding, K 54,898
Float, K 45,785
% Float 83.40%
Short Interest, K 9,191
Short Float 16.74%
Days to Cover 14.58
Short Volume Ratio 0.46
% of Insider Shareholders 16.60%
% of Institutional Shareholders 13.93%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -55,180 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -11,270 K
EBIT, $ -40,660 K
EBITDA, $ -39,670 K

Growth:

1-Year Return -3.98%
3-Year Return 168.91%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.21 on 11/13/25
Next Earnings Date 03/12/26
Earnings Per Share ttm -0.57
EPS Growth vs. Prev Qtr -133.33%
EPS Growth vs. Prev Year 36.36%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CADL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -29.24%
Return-on-Assets % -22.63%
Profit Margin % 0.00%
Debt/Equity 0.06
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 4.38
Book Value/Share 1.46
Interest Coverage -25.40
60-Month Beta -0.93
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar